Andrew Chapman

Thomas Jefferson University

$1,014,774

Attributed

$1,014,774

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $3.7M · FY2021–25

$5M$3.8M$2.5M$1.3M$0

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$16,223,163 · 2

By mechanism

P30$16,223,163 · 2

Top collaborators

No co-investigators on record.

Most similar at Thomas Jefferson University

Same institution · by research overlap

Christine M Eischen$17,498,082
Laura N. Gitlin$28,803,044

Others in their field

Other Emerging Leaders on “Malignant Neoplasms”

Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Leonard Freedmand · Leidos Biomedical Research, Inc.$108,968,336
Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
Martha Hering · Westat, Inc.$57,098,843

Research focus

Malignant NeoplasmsClinical ResearchCommunitiesCatchment AreaInnovationTranslational ResearchPhiladelphiaCancer CenterUniversitiesLeadershipTrainingProgramsScientistResearch PersonnelServicesFundingClinical CareMemberInfrastructureMissionStrategic PlanningResource SharingDisciplineMedical Research